SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Versant Venture Capital VI, L.P.

(Last) (First) (Middle)
ONE SANSOME STREET
SUITE 3630

(Street)
SAN FRANCISCO CA 94104

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Oyster Point Pharma, Inc. [ OYST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/04/2019
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.001 per share 11/04/2019 C 10,420 A (1) 12,438 I See footnotes(2)(4)
Common Stock, par value $0.001 per share 11/04/2019 C 1,654,359 A (1) 1,974,798 I See footnotes(3)(4)
Common Stock, par value $0.001 per share 11/04/2019 P 27,500 A $16 2,002,298 I See footnotes(3)(4)
Common Stock, par value $0.001 per share 11/04/2019 C 1,941,500 A (1) 1,941,500 D(5)
Common Stock, par value $0.001 per share 11/04/2019 C 495,388 A (1) 2,436,888 D(5)
Common Stock, par value $0.001 per share 11/04/2019 P 125,000 A $16 2,561,888 D(5)
Common Stock, par value $0.001 per share 11/04/2019 C 566,158 A (1) 566,158 I See footnote(6)
Common Stock, par value $0.001 per share 11/04/2019 P 437,500 A $16 1,003,658 I See footnote(6)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Convertible Preferred Stock (1) 11/04/2019 C 10,420 (1) (1) Common Stock, par value $0.001 per share 10,420 (1) 0 I See footnotes(2)(4)
Series A Convertible Preferred Stock (1) 11/04/2019 C 1,654,359 (1) (1) Common Stock, par value $0.001 per share 1,654,359 (1) 0 I See footnotes(3)(4)
Series A Convertible Preferred Stock (1) 11/04/2019 C 1,941,500 (1) (1) Common Stock, par value $0.001 per share 1,941,500 (1) 0 D(5)
Series B Convertible Preferred Stock (1) 11/04/2019 C 495,388 (1) (1) Common Stock, par value $0.001 per share 495,388 (1) 0 D(5)
Series B Convertible Preferred Stock (1) 11/04/2019 C 566,158 (1) (1) Common Stock, par value $0.001 per share 566,158 (1) 0 I See footnote(6)
1. Name and Address of Reporting Person*
Versant Venture Capital VI, L.P.

(Last) (First) (Middle)
ONE SANSOME STREET
SUITE 3630

(Street)
SAN FRANCISCO CA 94104

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Versant Ventures VI GP, L.P.

(Last) (First) (Middle)
ONE SANSOME STREET
SUITE 3630

(Street)
SAN FRANCISCO CA 94104

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Versant Ventures VI GP-GP, LLC

(Last) (First) (Middle)
ONE SANSOME STREET
SUITE 3630

(Street)
SAN FRANCISCO CA 94104

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Versant Vantage I, L.P.

(Last) (First) (Middle)
ONE SANSOME STREET
SUITE 3630

(Street)
SAN FRANCISCO CA 94104

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Versant Vantage I GP, L.P.

(Last) (First) (Middle)
ONE SANSOME STREET
SUITE 3630

(Street)
SAN FRANCISCO CA 94104

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Versant Vantage I GP-GP, LLC

(Last) (First) (Middle)
ONE SANSOME STREET
SUITE 3630

(Street)
SAN FRANCISCO CA 94104

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Versant Ventures IV, LLC

(Last) (First) (Middle)
ONE SANSOME STREET
SUITE 3630

(Street)
SAN FRANCISCO CA 94104

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Versant Venture Capital IV, L.P.

(Last) (First) (Middle)
ONE SANSOME STREET
SUITE 3630

(Street)
SAN FRANCISCO CA 94104

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Versant Side Fund IV, L.P.

(Last) (First) (Middle)
ONE SANSOME STREET
SUITE 3630

(Street)
SAN FRANCISCO CA 94104

(City) (State) (Zip)
Explanation of Responses:
1. These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's Common Stock ("Shares"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date.
2. Shares held by Versant Side Fund IV, L.P. ("Versant Side Fund IV").
3. Shares held by Versant Venture Capital IV, L.P. ("Versant IV").
4. Versant Ventures IV, LLC ("Versant Ventures IV") is the sole general partner of each of Versant IV and Versant Side Fund IV. Each of Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, Kirk G. Nielsen, Thomas F. Woiwode and Robin L. Praeger, as managing members of Versant Ventures IV, may be deemed to share voting and dispositive power over the shares held by Versant IV and Versant Side Fund IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports.
5. Shares directly held by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Each of Bradley J. Bolzon, Jerel C. Davis, Kirk G. Nielsen, Robin L. Praeger and Thomas F. Woiwode, and as November 1, 2019 Clare Ozawa, as managing members of Versant Ventures VI GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant VI; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein.
6. Shares held by Versant Vantage I, L.P. ("Versant Vantage"). Versant Vantage I GP, L.P. ("Versant Vantage I GP") is the general partner of Versant Vantage, and Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the general partner of Versant Vantage I GP. Each of Bradley J. Bolzon, Jerel C. Davis, Clare Ozawa, Robin L. Praeger and Thomas F. Woiwode, as managing members of Versant Vantage I GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant Vantage; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly, files separate Section 16 reports.
Remarks:
/s/ Versant Venture Capital VI, L.P. By: Versant Ventures VI GP, L.P Its: General Partner By: Versant Ventures VI GP-GP, LLC By: Robin L. Praeger Its: Manager 11/04/2019
/s/ Versant Ventures VI GP, L.P. By: Versant Ventures VI GP-GP, LLC Its: General Partner By: Robin L. Praeger Its: Manager 11/04/2019
/s/ Versant Ventures VI GP-GP, LLC By: Robin L. Praeger Its: Manager 11/04/2019
/s/ Versant Vantage I, L.P. By: Versant Vantage I GP, L.P. Its: General Partner By: Versant Vantage I GP-GP, LLC Its: General Partner By: Robin L. Praeger Its: Manager 11/04/2019
/s/ Versant Vantage I GP, L.P. By: Versant Vantage I GP-GP, LLC Its: General Partner By: Robin L. Praeger Its: Manager 11/04/2019
/s/ Versant Vantage I GP-GP, LLC By: Robin L. Praeger Its: Manager 11/04/2019
/s/ Versant Ventures IV, LLC By: Robin L. Praeger Its: Manager 11/04/2019
/s/ Versant Venture Capital IV, L.P. By: Versant Ventures IV, LLC Its: General Partner By: Robin L. Praeger Its: Manager 11/04/2019
/s/ Versant Side Fund IV, L.P. By: Versant Ventures IV, LLC Its: General Partner By: Robin L. Praeger Its: Manager 11/04/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.